Identifying a subset of patients with DCIS who have a low likelihood of residual disease at surgical excision following a core needle biopsy
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24649
Abstract: Current randomized controlled trials are investigating the outcomes of non‐surgical treatment for patients with ductal carcinoma in situ (DCIS). We sought to evaluate pre‐operative factors associated with no residual disease at definitive resection following a… read more here.
Keywords: residual disease; needle biopsy; core needle; following core ... See more keywords